Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients [1]

Annals of Neurology

Volumn 50, Issue 5, 2001, Pages 686-687

  Pierantozzi, Mariangela ^a,f   Pietroiusti, Antonio ^b   Galante, Alberto ^b   Sancesario, Giuseppe ^a   Lunardi, Gianluigi ^c   Fedele, Ernesto ^d   Giacomini, Patrizia ^e   Stanzione, Paolo ^a,f  

^a Clinica Neurologica   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LEVODOPA; OMEPRAZOLE; PLACEBO;

ADULT; AGED; AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HUMANS; INTESTINAL ABSORPTION; LEVODOPA; OMEPRAZOLE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034761332     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1267     Document Type: Letter

References (6)

1. Parkinsonism: Onset, progression and mortality
2. Helicobacter pylori modulation of gastric acid
3. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: Relation to gastric mucosal ascorbic acid concentration and effect of H. pylori eradication
4. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
5. Unified Parkinson's disease rating scale